Smartphone-based self-monitoring in bipolar disorder: evaluation of usability and feasibility of two systems.
Journal
International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983
Informations de publication
Date de publication:
04 Jan 2019
04 Jan 2019
Historique:
received:
03
08
2018
accepted:
03
10
2018
entrez:
6
1
2019
pubmed:
6
1
2019
medline:
6
1
2019
Statut:
epublish
Résumé
The aims of the present multicenter pilot study were to examine the feasibility and usability of two different smartphone-based monitoring systems (the Pulso system and the Trilogis-Monsenso system) from two IT companies in patients with bipolar disorder, developed and selected to be testes as a part of a European Union funded Pre-Commercial Procurement (the NYMPHA-MD project). Patients with bipolar disorder (ICD-10), > 18 years of age during a remitted, partial remitted or mild to moderate depressive state (HDRS-17 < 25) from Italy, Spain and Denmark were included. Patients were randomized 1:1 to the use of one of two smartphone-based monitoring systems. The randomization was stratified according to study location (Italy, Spain, Denmark) and all patients were followed for a 4 weeks study period. Usability and feasibility were evaluated using the Computer System Usability Questionnaire, and the Usefulness, Satisfaction, and Ease of use Questionnaire. A total of 60 patients aged 18-69 years with bipolar disorder (ICD-10) recruited from Italy, Spain, Denmark were included-59 patients completed the study. In Denmark, the patients evaluated the Trilogis-Monsenso system with a statistically significant higher usability compared with the Pulso system. In Italy and Spain, the patients evaluated no statistically significant difference between the two systems in any of the categories, except for the usefulness category favoring the Trilogis-Monsenso system (z = 2.68, p < 0.01). Both monitoring systems showed acceptable usability and feasibility. There were differences in patient-based evaluations of the two monitoring systems related to the country of the study. Studies investigating the usability and feasibility during longer follow-up periods could perhaps reveal different findings. Future randomized controlled trials investigating the possible positive and negative effects of smartphone-based monitoring systems are needed.
Sections du résumé
BACKGROUND
BACKGROUND
The aims of the present multicenter pilot study were to examine the feasibility and usability of two different smartphone-based monitoring systems (the Pulso system and the Trilogis-Monsenso system) from two IT companies in patients with bipolar disorder, developed and selected to be testes as a part of a European Union funded Pre-Commercial Procurement (the NYMPHA-MD project).
METHODS
METHODS
Patients with bipolar disorder (ICD-10), > 18 years of age during a remitted, partial remitted or mild to moderate depressive state (HDRS-17 < 25) from Italy, Spain and Denmark were included. Patients were randomized 1:1 to the use of one of two smartphone-based monitoring systems. The randomization was stratified according to study location (Italy, Spain, Denmark) and all patients were followed for a 4 weeks study period. Usability and feasibility were evaluated using the Computer System Usability Questionnaire, and the Usefulness, Satisfaction, and Ease of use Questionnaire.
RESULTS
RESULTS
A total of 60 patients aged 18-69 years with bipolar disorder (ICD-10) recruited from Italy, Spain, Denmark were included-59 patients completed the study. In Denmark, the patients evaluated the Trilogis-Monsenso system with a statistically significant higher usability compared with the Pulso system. In Italy and Spain, the patients evaluated no statistically significant difference between the two systems in any of the categories, except for the usefulness category favoring the Trilogis-Monsenso system (z = 2.68, p < 0.01).
CONCLUSIONS
CONCLUSIONS
Both monitoring systems showed acceptable usability and feasibility. There were differences in patient-based evaluations of the two monitoring systems related to the country of the study. Studies investigating the usability and feasibility during longer follow-up periods could perhaps reveal different findings. Future randomized controlled trials investigating the possible positive and negative effects of smartphone-based monitoring systems are needed.
Identifiants
pubmed: 30610400
doi: 10.1186/s40345-018-0134-8
pii: 10.1186/s40345-018-0134-8
pmc: PMC6320330
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1Subventions
Organisme : EU
ID : Nº 610462
Références
Arch Gen Psychiatry. 2003 Mar;60(3):261-9
pubmed: 12622659
Int J Neuropsychopharmacol. 2003 Jun;6(2):127-37
pubmed: 12890306
Bipolar Disord. 2004 Feb;6(1):62-6
pubmed: 14996142
Eur Neuropsychopharmacol. 2005 Aug;15(4):425-34
pubmed: 15935623
Bipolar Disord. 2007 Aug;9(5):531-5
pubmed: 17680925
Annu Rev Clin Psychol. 2008;4:1-32
pubmed: 18509902
Psychol Assess. 2009 Dec;21(4):463-75
pubmed: 19947781
Bipolar Disord. 2010 May;12(3):327-34
pubmed: 20565440
Clin Psychol Rev. 2010 Aug;30(6):794-804
pubmed: 20619520
J Med Internet Res. 2011 Jun 30;13(2):e42
pubmed: 21719411
Eur Eat Disord Rev. 2012 Jan;20(1):1-8
pubmed: 21796737
Arch Gen Psychiatry. 1990 Jun;47(6):589-93
pubmed: 2190539
Acta Psychiatr Scand. 2012 Apr;125(4):335-41
pubmed: 22283440
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
Clin Psychol Rev. 2012 Aug;32(6):510-23
pubmed: 22721999
Acta Psychiatr Scand. 2013 Sep;128(3):194-202
pubmed: 23331090
Cochrane Database Syst Rev. 2013 Sep 09;(9):CD005330
pubmed: 24018460
J Med Internet Res. 2013 Nov 15;15(11):e247
pubmed: 24240579
J Behav Ther Exp Psychiatry. 2015 Mar;46:14-8
pubmed: 25164093
J Affect Disord. 2015 Mar 15;174:23-30
pubmed: 25479050
BMJ Open. 2015 May 21;5(5):e007504
pubmed: 25998036
Psychol Med. 2015 Oct;45(13):2691-704
pubmed: 26220802
Lancet Psychiatry. 2015 Jun;2(6):564-70
pubmed: 26360452
J Med Internet Res. 2016 May 31;18(5):e121
pubmed: 27245693
J Med Internet Res. 2016 Jun 10;18(6):e135
pubmed: 27287668
World J Psychiatry. 2016 Jun 22;6(2):269-82
pubmed: 27354970
Harv Rev Psychiatry. 2017 May/Jun;25(3):146-154
pubmed: 28234658
J Med Internet Res. 2017 May 17;19(5):e172
pubmed: 28526671
J Affect Disord. 2018 Aug 15;236:199-206
pubmed: 29747137
Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
pubmed: 6080235
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692